Arkolith/Insider Trading/CNSP/Form 4/A

Gumulka Jerzy

DirectorCNS Pharmaceuticals, Inc. (CNSP) · full profile →Form 4/A · filed Oct 12, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 21, 2023Grant(A)39K——45K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001683168-23-007111) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML